Saturday 17 October 2026 Export AUPH’s income statement to Excel — free account

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc’s revenue for fiscal 2025 (year ended December 2025) was $283.1 million, up 20.4% from fiscal 2024. In the quarter to June 2026, revenue grew 18.9%, EPS grew 81.3%, free cash flow grew 19.1% and total debt fell 25.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

16.51 0.22 −1.32%

Follow AUPH

Alert me

Market cap: $2.2B
P/E: 6.9×
Fwd P/E: 16.5×
Dividend yield: —
F-score: 8/9
Altman Z: 7.86
Beneish M: −0.88
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	66.12%	64.98%	59.91%	20.65%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	7	7	8	9
ROA Full definition →	48.52%	48.54%	44.11%	14.46%
ROIC Full definition →	40.76%	34.24%	30.35%	71.84%
Return on Tangible Assets Full definition →	70.86%	75.37%	71.74%	21.34%
Average Days of Receivables Full definition →	48.20	60.17	53.46	42.19
Free Cash Flow per Share Full definition →	1.35	1.26	1.01	0.91
Free Cash Flow Full definition →	175.07	166.64	135.41	119.87
Capital Expenditures Full definition →	(0.18)	(0.27)	(0.25)	(0.24)
Other line items
Cash ROIC Full definition →	15.89%	16.76%	13.13%	15.50%
Accounts Receivable Turnover Full definition →	7.67	6.66	7.26	7.91
Accounts Payable Turnover Full definition →	11.90	8.89	7.69	1.00
Inventory Turnover Full definition →	0.66	0.66	0.77	0.70
Average Days of Payables Full definition →	21.08	31.74	37.02	27.47
Days of Inventory on Hand Full definition →	548.68	553.66	510.54	555.76
Tax Rate Full definition →	0.96	1.23	1.52	(0.02)
Research and Development Expense of Revenue Full definition →	12.79%	11.48%	11.48%	11.18%
Selling, General and Administrative Expense of Revenue Full definition →	32.41%	34.69%	35.96%	41.22%
Share Based Compensation of Revenue Full definition →	4.69%	5.77%	5.19%	6.36%
Interest Coverage Full definition →	34.25	30.38	26.43	18.09
Operating CF/Net income Full definition →	0.56	0.56	0.47	1.54
Depreciation/Fixed assets Full definition →	10.41	9.77	9.21	8.58
Capex/Depreciation Full definition →	(0.01)	(0.01)	(0.01)	(0.01)
Revenue per Share Full definition →	2.39	2.25	2.11	2.02
Operating CF per Share Full definition →	1.35	1.26	1.01	0.91
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly